Symbicort Sales Data

Rank 31 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Symbicort U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 31 (1) 9.63% 7.48%
Q3 2013 32 (2) -3.15% -18.04%
Q2 2013 30 (4) 1.89% 4.12%
Q1 2013 34 (3) 10.70% -4.45%
Q4 2012 37 (6) 10.64% 12.94%
Q3 2012 43 (3) 4.37% 6.95%
Q2 2012 46 (5) 1.42% 3.51%
Q1 2012 51 (5) 8.71% 5.59%
Q4 2011 56 (8) 11.05% 17.58%
Q3 2011 64 (4) -4.65% 0.27%
Q2 2011 60 (2) 0.64% 0.41%
Q1 2011 62

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
February 19, 2010FDA Issues Warning On 4 Widely-Used Asthma Drugs
February 18, 2010FDA Issues Warning on Key Asthma Drugs
February 9, 2009Inhaled Corticosteroids Boost Pneumonia Risk in COPD
December 12, 2008Allergists Respond to FDA Committee Recommendation on Asthma Medication, Encourage Patients with Questions to Contact Physicians
December 12, 2008AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on Symbicort
December 11, 2008FDA Panel Mulls Safety of Asthma Meds
Hide
(web5)